Advancing innovation in accelerated cancer diagnosis
Innovate UK, on behalf of the Office for Life Sciences’ (OLS) (UK) · National scheme · 1 eligible country
What this scheme funds
This UK programme funds the clinical validation and evaluation of new technologies and devices that detect cancer earlier. Up to 25.4 million pounds is available across all successful applicants to help move early diagnostic innovations closer to real world clinical use.
diagnostics · digital-health · public-health
Do you qualify for this scheme?
Tell us your website and we'll check this scheme's own conditions against what your company does.
Only the website is required.
Who it is for
Organisations from the public, non profit or private sector in the UK developing early cancer diagnostic technologies ready for clinical validation are best suited to this call.
The scheme in detail
- Agency
- Innovate UK, on behalf of the Office for Life Sciences’ (OLS) (UK)
- Eligible countries (1)
- United Kingdom
- Funding
- €4.6M
- Deadline
- 28 Oct 2026
- Applicant type
- Not stated by the agency.
- Eligible applicants
- public body, non-profit, private sector
- Also required
- Total scheme budget of 25.4 million pounds is shared across all recipients, not awarded per applicant.